Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Distribution Channel, Retail Pharmacies Lead, And Online Pharmacies Grow the Fastest The retail pharmacies held the largest revenue share of around 56.61% in the semaglutide market in 2024, owing to easy availability, robust distribution, and increasing consumer inclination for easy prescription refill orders
Tirzepatides dual-action mechanism, targeting both GLP-1 and GIP receptors, offers broader metabolic benefits, which may contribute to greater and more sustained weight loss compared to Semaglutide GLP-1, which primarily targets GLP-1 receptors
Do note that GLP-1 medicines are not currently licensed for reproductive health, including the treatment of PCOS
The therapeutic dose for weight loss goes up to 2.4 mg
US$ 23.01
US$ 24.45
US$ 24.15
US$ 28.80
US$ 29.67
US$ 26.77
US$ 22.74
US$ 24.52
US$ 26.81
US$ 20.55
